Atlas Trials

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

Clinical trial NCT02152995 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02152995
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland CarcinomaStage IV Thyroid Gland Follicular Carcinoma AJCC v7Stage IV Thyroid Gland Papillary Carcinoma AJCC v7Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7
Start date
2014-08-14
Primary completion
2021-08-25
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.